1. Home
  2. CCSI vs FDMT Comparison

CCSI vs FDMT Comparison

Compare CCSI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

N/A

Current Price

$43.00

Market Cap

684.3M

Sector

Technology

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$12.27

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCSI
FDMT
Founded
2021
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
684.3M
695.3M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
CCSI
FDMT
Price
$43.00
$12.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
★ $50.00
$28.09
AVG Volume (30 Days)
108.7K
★ 957.9K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.79
EPS
★ 3.88
N/A
Revenue
★ $349,696,000.00
$85,209,000.00
Revenue This Year
$3.40
N/A
Revenue Next Year
$4.22
$51.94
P/E Ratio
$11.11
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$20.20
$6.96
52 Week High
$45.68
$16.93

Technical Indicators

Market Signals
Indicator
CCSI
FDMT
Relative Strength Index (RSI) 65.92 48.62
Support Level $33.37 $8.68
Resistance Level N/A $13.64
Average True Range (ATR) 2.06 0.94
MACD 0.67 0.11
Stochastic Oscillator 75.53 56.17

Price Performance

Historical Comparison
CCSI
FDMT

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: